PTPRC and B-cell chronic lymphocytic leukemia: CLL is characteristically defined as an accumulation of CD45+ B lymphocytes with phenotypic expression of cell-surface markers CD5, CD19, and CD23, with dim—or intermediate—expression of CD45R (B220)1.